In London commuters can select their underground route based on air quality. Flats with mould also present a health risk for their inhabitants.
Therefore, a Miami woman has created a startup enabling those affected to verify if health symptoms are related to mould toxicity and receive appropriate treatment.
After answering screening questions, patients can undergo targeted tests, encompassing 30 years’ research into mould as a cause of disease. Specialised biomarker testing checks for chronic inflammation, as well as immune and hormone regulation markers.
Based on the results and patients’ medical history, a personalised treatment programme is drafted with medication sent to patients directly.
A wearable device might prove useful. Lung function tests, meanwhile, could soon be carried out in patients’ homes.
